GPR155 and gastric cancer: By looking into patients with stage II/III GC, GPR155 mRNA levels were lower in GC tissues from patients with metachronous hematogenous metastasis compared to those from patients without metachronous hematogenous metastasis, though the difference was not statistically significant (Fig. 3A).